3/17
08:00 am
klrs
Kalaris Reports Full Year 2025 Financial Results and Provides Business Updates
Medium
Report
Kalaris Reports Full Year 2025 Financial Results and Provides Business Updates
3/15
01:05 am
klrs
Low
Report
2/21
02:04 am
klrs
Kalaris Therapeutics (NASDAQ:KLRS) was upgraded by analysts at
Wall Stre
Medium
Report
Kalaris Therapeutics (NASDAQ:KLRS) was upgraded by analysts at
Wall Stre
1/31
01:33 am
klrs
Kalaris Therapeutics (NASDAQ:KLRS) was downgraded by analysts at
Wall St
Low
Report
Kalaris Therapeutics (NASDAQ:KLRS) was downgraded by analysts at
Wall St
1/28
04:05 pm
klrs
Kalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting
Low
Report
Kalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting
1/24
12:30 am
klrs
Kalaris Therapeutics (NASDAQ:KLRS) was downgraded by analysts at
Wall St
Low
Report
Kalaris Therapeutics (NASDAQ:KLRS) was downgraded by analysts at
Wall St
12/24
06:15 am
klrs
Kalaris Therapeutics (NASDAQ:KLRS) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.
Low
Report
Kalaris Therapeutics (NASDAQ:KLRS) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.
12/23
07:01 am
klrs
Kalaris Therapeutics (NASDAQ:KLRS) was given a new $19.00 price target on by analysts at Chardan Capital.
Medium
Report
Kalaris Therapeutics (NASDAQ:KLRS) was given a new $19.00 price target on by analysts at Chardan Capital.
12/20
01:30 am
klrs
Kalaris Therapeutics (NASDAQ:KLRS) was upgraded by analysts at
Wall Stre
High
Report
Kalaris Therapeutics (NASDAQ:KLRS) was upgraded by analysts at
Wall Stre